Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05136703 · ClinicalTrials.gov registry record · NA

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

A NA study of Depression and Inflammation, sponsored by Florida International University.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
2
Study locations

NCT05136703 is a NA study of Depression and Inflammation that is actively recruiting participants, run by Florida International University. The registered enrollment target is 150 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05136703, a NA study of Depression and Inflammation, is actively recruiting participants, sponsored by Florida International University.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this randomized controlled trial is to understand how a cognitive-behavioral treatment (a form of psychological treatment) for depression changes the gut microbiome (micro-organisms that regulate the health of the gut), immune system, and the brain functioning in people living with HIV.

Interventions

  • BEHAVIORAL Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD)
  • BEHAVIORAL Antiretroviral Therapy (ART) Adherence Counseling

Study Locations (2)

Florida

  • University of Miami Neuroimaging Facility - Coral Gables
  • Care Resource - Midtown Miami - Miami

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-08-30
Est. Completion 2027-12-31
Phase NA

Sponsor

Florida International University

89 total trials

What the Registry Record Tells You About NCT05136703

The ClinicalTrials.gov registry entry for NCT05136703 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD) is the first listed.

NCT05136703 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05136703 about?

NCT05136703 is a clinical study titled "Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)". The purpose of this randomized controlled trial is to understand how a cognitive-behavioral treatment (a form of psychological treatment) for depression changes the gut microbiome (micro-organisms that regulate the health of the gut), immune system, and the brain functioning in people living with HI...

What is the current status of trial NCT05136703?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-08-30. Estimated completion is 2027-12-31.

What conditions does trial NCT05136703 study?

This clinical trial studies the following conditions: Depression, Inflammation, HIV-1-infection.

What interventions are being tested in trial NCT05136703?

The interventions under investigation include: Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD) (BEHAVIORAL), Antiretroviral Therapy (ART) Adherence Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT05136703?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05136703 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.